Aster Capital Management’s BridgeBio Oncology BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87K Buy
+21,220
New +$165K 0.03% 483

Other funds holding BBOT

Aster Capital Management's BBOT Position: Q3 2026 in Review

Aster Capital Management opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 21,220 shares worth $87K. The stake represents 0.03% of the portfolio and ranks #483 among its holdings.

89 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • Aster Capital Management held 21,220 shares of BridgeBio Oncology worth $87K as of Q3 2026.
  • BridgeBio Oncology was a new Aster Capital Management position in Q3 2026.
  • BridgeBio Oncology made up 0.03% of Aster Capital Management's portfolio in Q3 2026, its #483 holding.
  • 89 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.